FMP
GlucoTrack, Inc.
GCTK
NASDAQ
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
0.353 USD
-0.005 (-1.42%)
Gordon Thompson
Feb 4, 2025
On February 4, 2025, Glucotrack, Inc. (NASDAQ:GCTK) executed a 20-for-1 reverse stock split. Glucotrack is a medical technology company focused on developing innovative solutions for diabetes management. The reverse stock split is a strategic move often used by companies to increase the per-share price by reducing the number of shares outstanding. In conjunction with the reverse stock split, Glucotrack announced a public offering of approximately 2.6 million shares at $1.15 per share. This offe...
GlobeNewsWire
Jun 10, 2024
Rutherford, NJ, June 10, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the Sidoti Small Cap Investor Conference.
InvestorPlace
Apr 13, 2023
GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it's planning for a firm commitment underwritten public offering.
PennyStocks
Apr 11, 2023
Can these tips help you make money with penny stocks in 2023? The post Spotting Winning Penny Stocks: 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.